Optellum

Optellum is a health technology company based in Oxford, specializing in AI-powered clinical decision support software for lung disease diagnosis and treatment, particularly lung cancer. Founded in 2016 by former scientists from the Oxford University Computer Vision Lab, Optellum aims to enhance lung cancer survival rates through earlier and more accurate detection of malignant lung nodules. The company's flagship product, the Optellum Virtual Nodule Clinic, is an AI-driven platform that analyzes CT scans to distinguish between benign and malignant lung nodules at their earliest and most treatable stage. This capability is crucial, as early detection significantly improves survival rates. Optellum collaborates with healthcare organizations, including NHS Trusts in the UK and major industry players like GE Healthcare and Johnson & Johnson, to integrate AI into lung cancer screening and management. The company has achieved important regulatory milestones, including FDA clearance and CE certification, allowing its software to be used in clinical settings worldwide.

• Employees 50
• Founded 2016
• Annual Revenue $2500000
• Total Funding $15251766